Related Experiment Video
Updated: May 2, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
A new infectious encephalopathy syndrome, clinically mild encephalopathy associated with excitotoxicity (MEEX)
Nozomi Hirai1, Daisuke Yoshimaru2, Yoko Moriyama1
1Department of Pediatrics, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.
Abstract:
Acute infectious encephalopathy is often observed in children in East Asia including Japan. More than 40% of the patients remain unclassified into specific syndromes. To investigate the underlying pathomechanisms in those with unclassified encephalopathy, we evaluated brain metabolism by MR spectroscopy. Among seven patients with acute encephalopathy admitted to our hospital from June 2016 to May 2017, three were classified into acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). The other four showed consciousness disturbance lasting more than three days with no parenchymal lesion visible on MRI, which led to a diagnosis of unclassified encephalopathy. MR spectroscopy in these four patients, however, revealed an increase of glutamine with a normal N-acetyl aspartate level on days 5 to 8, which had normalized by follow-up studies on days 11 to 16. The four patients clinically recovered completely. Among 27 patients with encephalopathy, including the present seven patients, admitted to our hospital from January 2015 to March 2017, seven (26%) were classified into this type, which we propose is a new encephalopathy syndrome, clinically mild encephalopathy associated with excitotoxicity (MEEX). MEEX is the second most common subtype, following AESD (30%). This study suggests that excitotoxicity may be a common underlying pathomechanism of acute infectious encephalopathy, and prompt astrocytic neuroprotection from excitotoxicity may prevent progression of MEEX into AESD.
Insights
A new encephalopathy syndrome, mild encephalopathy associated with excitotoxicity (MEEX), is identified in children. This condition, characterized by elevated brain glutamine, suggests excitotoxicity as a common mechanism in acute infectious encephalopathy.
Area of Science:
- Pediatric Neurology
- Neuroscience
- Metabolic Disorders
Background:
- Acute infectious encephalopathy is prevalent in East Asian children, with over 40% remaining unclassified.
- Identifying specific syndromes and underlying mechanisms is crucial for effective treatment.
Purpose of the Study:
- To investigate the pathomechanisms of unclassified encephalopathy in children using MR spectroscopy.
- To propose a new encephalopathy syndrome based on metabolic findings and clinical presentation.
Main Methods:
- MR spectroscopy was used to evaluate brain metabolism in seven pediatric patients with acute encephalopathy.
- Patients were classified into known syndromes or diagnosed with unclassified encephalopathy based on clinical and imaging findings.
Main Results:
- Four patients with unclassified encephalopathy showed increased brain glutamine and normal N-acetyl aspartate on MR spectroscopy during the acute phase.
- These metabolic abnormalities normalized upon clinical recovery.
- The proposed new syndrome, mild encephalopathy with excitotoxicity (MEEX), accounted for 26% of encephalopathy cases, second only to acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) at 30%.
Conclusions:
- Excitotoxicity is suggested as a common pathomechanism in acute infectious encephalopathy.
- MEEX represents a distinct clinical entity within acute infectious encephalopathy.
- Early astrocytic neuroprotection may prevent MEEX progression to more severe forms like AESD.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Hepatic Encephalopathy

